Design, optimization and evaluation of aceclofenac fast dissolving tablets employing starch glutarate: A new superdisintegrant by Santosh Kumar, Rada & Satya Yagnesh, T. Naga
 Santosh Kumar et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2):259-269 
ISSN: 2250-1177                                                                                     [259]                                                                                     CODEN (USA): JDDTAO 
Available online on 15.03.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Design, optimization and evaluation of aceclofenac fast dissolving tablets 
employing starch glutarate: A new superdisintegrant 
R. Santosh Kumar*, T. Naga Satya Yagnesh  
GITAM Institute of Pharmacy, GITAM (Deemed to be University), Rushikonda, Visakhapatnam, A.P 530045, INDIA 
 
ABSTRACT 
In solid dosage forms, fast dissolving tablets has proven the best way for ease of administration for the pediatrics and geriatric patients. The 
current study involves in the evaluation of starch glutarate as a superdintegrant in the formulation of fast dissolving tablets of poorly soluble 
drugs employing 23factorial design. Starch glutarate was synthesized by esterification process. The synthesized starch glutarate was subjected to 
physical and micromeritic evaluation. To establish as starch glutarate as a superdisintegrant, fast dissolving tablet of aceclofenac was prepared 
employing starch glutarate in different proportions in each case by direct compression method employing 23 factorial design. All fast dissolving 
tablets prepared were evaluated for drug content, hardness, friability, disintegration time and other dissolution characteristics like percent 
dissolved in 5 min (PD5), Dissolution efficiency in 5 min (DE5%) and first order rate constant (K1). The starch glutarate prepared was found to be 
fine, free flowing amorphous powder. Starch glutarate exhibited good swelling in water. Fourier transform infrared spectra (FTIR) and 
Differential scanning calorimetry (DSC) study indicated the absence of interaction between aceclofenac and starch glutarate. All the fast 
dissolving tablets formulated employing starch glutarate were of good quality with regard to drug content (100±5%), hardness (3.6–4 kg/sq. 
cm), and friability (0.12-0.15%). The optimized formulation F8 has the least disintegration time i.e., 30±0.02s. The in vitro wetting time was less 
(i.e., 90s) in optimized formulation F8. The cumulative drug dissolved in the optimized formulation F8 was found to be 99.15±0.56% in 15 min. 
Starch glutarate was found to be a superdisintegrant which enhanced the dissolution efficiency when combined with crospovidone, 
croscarmellose sodium, with the aceclofenac and hence it could be used in the formulation of fast dissolving tablets to provide immediate release 
of the contained drug within 15 minutes. 
Keywords: Fast dissolving, Superdisintegrant, Starch glutarate, Dissolution efficiency. 
 
Article Info: Received 09 Feb 2019;     Review Completed 10 March 2019;     Accepted 12 March 2019;     Available online 15 March 2019 
Cite this article as: 
Santosh Kumar R, Satya Yagnesh TN, Design, optimization and evaluation of aceclofenac fast dissolving tablets employing 
starch glutarate: A new superdisintegrant, Journal of Drug Delivery and Therapeutics. 2019; 9(2):259-269    
http://dx.doi.org/10.22270/jddt.v9i2.2564                                                           
*Address for Correspondence:  
R. Santosh Kumar, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Rushikonda, Visakhapatnam, A.P 530045, INDIA 
 
 
INTRODUCTION 
In the present scenario the fast dissolving tablets (FDT) of 
solid dosage form helps in the redemption of complications 
facing by the patients like difficulty in swallowing, nausea, 
retching, and motion sickness complications. Fast dissolving 
tablets contain indicated substances which disintegrate 
rapidly, usually within few seconds when placed upon 
tongue requiring additional water to facilitate swallowing 1. 
Fast dissolving tablets overcome this problem and provide 
the advantages for pediatrics, geriatric 2-3, bedridden, 
disabled patients and also for who may have difficulty in 
swallowing tablets, capsules and liquid orals. FDT will 
rapidly disintegrate in the mouth without the need of water 
4-5. Fast dissolving tablet formulation provides sufficient 
strength, quick disintegration/ dissolution in the mouth 
without water 6, rapid dissolution and absorption of the 
drug, which will produce the quick onset of action. Pre 
gastric absorption of FDT can result in improved 
bioavailability and as a consequence of reduced dose 7. 
Various techniques can be used to formulate fast dissolving 
tablets. Direct compression one of the techniques which 
need the administration of superdisintegrant or highly water 
soluble excipients into the formulation to produce fast tablet 
disintegration.  Direct compression does not need the 
utilization of water or heat during the formulation procedure 
and is the ideal process for moisture and heat-liable 
medication. The aim of the work was to formulate and 
characterize fast-dissolving tablets of aceclofenac by using 
optimization techniques for rapid dissolution of drug and 
absorption employing a new superdisintegrant i.e., starch 
glutarate. Optimization technique give both a depth of 
understanding and an ability to explore and define ranges for 
formulation and processing factors with a rational approach 
to the selection of various experimental and manufacturing 
step for a given product, to quantitatively select a 
formulation. It is at this mark that optimization can become a 
useful tool to quantitative a formulation that has been 
qualitatively measured. 
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The present study deals with an attempt of systematic 
formulation approach for optimization of aceclofenac fast 
dissolving tablets employing starch glutarate, crospovidone, 
and croscarmellose sodium as superdisintegrants. A 23 
factorial design was applied to investigate the main and 
interaction effects of the three formulation variables i.e., 
starch glutarate (A), crospovidone (B), croscarmellose 
sodium (C) in each case to find the formula with less 
disintegration time and more dissolution efficiency 5 min 
and to authorize the arbitrary selection of tablets with 
immediate release of drug with in 5 min. 
MATERIALS AND METHODS 
Materials: 
Sodium hydroxide, mannitol was purchased from Finar 
chemicals Ltd, Ahmedabad. Potato starch, aceclofenac, 
crospovidone, croscarmellose sodium was obtained from 
Yarrow chem. Products, Mumbai.  Microcrystalline cellulose 
was bought from Qualigens fine chemicals, Mumbai. Talc and 
magnesium stearate was obtained from Molychem, Mumbai. 
Preparation of starch glutarate (a novel 
Superdisintegrant): 
Initially 10g of glutaric acid and 10g of potato starch was 
dissolved in 25ml distilled water. Then, pH of the solution 
was adjusted to, pH 3.5. This dispersion was conditioned for 
16 hrs.  After conditioning the dispersion was kept it in an 
oven at 60º C until dried. The mass was washed with 
distilled water, to remove unreacted glutaric acid. The 
product was kept in oven at 600C until dried. The product 
obtained was ground and sieved (# 120).  
Characterization of starch glutarate: 
The starch glutarate prepared was evaluated for the 
following 
Solubility: 
The solubility of starch glutarate was tested in water, 
aqueous buffer of pH 1,2,3,4,5,6,7.4 and organic solvents like 
alcohol, acetone, dichloromethane, chloroform, and 
petroleum ether. 
pH: 
The pH of 3% w/v slurry was measured by pH meter. 
Melting point: 
The melting point was determined by using melting point 
apparatus. 
Viscosity: 
The viscosity of 1% dispersion in water was measured using 
ostwald viscometer. 
Swelling index: 
Starch glutarate (200 mg) was added to 10 ml of water and 
light liquid paraffin, taken in two different graduated test 
tubes and mixed. In the tubes the dispersion was allowed to 
stand for 12 h. The volumes of the sediment in the tubes 
were noted. The swelling index of the material was 
determined as follows.  
 
Test for gelling property:  
The gelling property (gelatinization) of the starch and starch 
glutarate prepared was evaluated by heating 7% w/v 
dispersion of each,   in water at 1000C for 30 min. 
Particle size: 
The particle size analysis was performed by sieving using 
standard sieves. 
Density: 
The density (g/cc) was measured by liquid displacement 
process using benzene as liquid. 
Bulk density: 
Both loose bulk density (LBD) and tapped bulk density 
(TBD) were calculated by transferring the accurate weighed 
amount of sample in 50 ml measuring cylinder, the granules 
without any agglomerates and determined the volume of 
packing and tapped 50 times on a plane surface and tapped 
volume of packing recorded LBD and TBD measured by 
following formula 8. 
 
 
Percentage compressibility index  
Percentage compressibility of powder mix was determined 
by Carr’s compressibility index calculated by the following 
formula 9. 
 
Where, TBD = Tapped bulk density; LBD = Loose bulk 
density. 
Angle of repose 
The frictional forces in loose powder or granules can be 
determined by the angle of repose. This is the highest angle 
possible between the surface of a mass of powder or 
granules and the horizontal plane. Angle of repose is 
measured by applying the next equation; 
                                                               
 
Where θ = angle of repose; h = height of pile; r = radius of 
pile. 
Fourier transform infrared (FTIR) spectroscopy: 
FTIR spectra of starch glutarate was recorded on samples 
prepared in potassium bromide (KBr) disks using a BRUKER 
FT –IR,(Tokyo, Japan). The preparation of samples was 
performed in (KBr) disks by means of a hydrostatic press at 
6-8 tons pressure. The scanning range was 500 to 4000 cm-1. 
X – Ray diffraction:  
Diffraction pattern of starch glutarate was recorded with an 
x-ray diffractometer (Analytical spectra’s Pvt. Ltd., 
Singapore). X-ray diffraction was performed at room 
temperature (300C) with a diffractometer; target, Cu(λ1.54 
A), filter, Ni; voltage,40 ⱪV; current 30mA; time constant 
10mm/s ; scanning rate 20/min; measured from 2.5-500 at 
full scale 200. 
Drug – Excipients compatibility studies: 
The compatibility of starch glutarate with the selected drug 
(aceclofenac) was evaluated in DSC and FTIR studies. 
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Differential Scanning Calorimetry (DSC): 
 DSC thermograms of aceclofenac, and their mixtures (1: 1) 
with starch glutarate were recorded on Perkin Elmer 
thermal analyser samples (2- 5 mg) were sealed into 
aluminium pans and scanned at a heating rate of 100C min-1 
over a temperature range 30 – 3500C. 
Infrared Spectroscopy:  
Fourier transform infra red (FTIR) spectra of aceclofenac, 
and their mixtures (1: 1) with starch glutarate were 
recorded on a Perkin Elmer, IR Spectrophotometer model: 
Spectrum RXI, using KBr disc as reference. 
Preparation of aceclofenac fast dissolving tablets 
The tablets were prepared by direct compression method 
employing 23 factorial design in which 3 independent 
variables {superdisintegrants i.e., starch glutarate (A), 
crospovidone (B), croscarmellose sodium (C)} and 1 
dependent variable (dissolution efficiency in 5 min) were 
selected. The composition of different formulation of 
aceclofenac fast dissolving tablets is given in table no 1, in 
which superdisintegrants were selected at 2 levels i.e., higher 
and lower. At the higher level i.e., 5% concentration of starch 
glutarate (A), crospovidone (B) and croscarmellose 
sodium(C) and at the lower level i.e., 0% concentration of 
starch glutarate (A), crospovidone (B) and croscarmellose 
sodium(C). For uniformity in particle size each ingredient 
was flown through #100 mesh sized screen before mixing. 
Starch glutarate, crospovidone, croscarmellose sodium, 
mannitol and microcrystalline cellulose were accurately 
weighed mixed using mortar and pestle, and then 
aceclofenac was added. Finally talc and magnesium stearate 
were administered to the powder mixture. Finally, the mixed 
blend was compressed by using eight station rotator press 
Karnawathi Machineries Pvt, Ltd., Ahmedabad, India). 
 
Table: 1: Formulae of Aceclofenac fast dissolving tablets employing starch glutarate. 
Ingredients (mg/tablet)   F1 F2 F3 F4 F5 F6 F7 F8 
Aceclofenac 100 100 100 100 100 100 100 100 
Starch glutarate --- 25 --- 25 --- 25 --- 25 
Croscarmellose Sodium --- --- 25 25 --- --- 25 25 
Crospovidone --- --- --- --- 25 25 25 25 
Mannitol 130 105 105 80 105 80 80 55 
Micro crystalline cellulose 250 250 250 250 250 250 250 250 
Talc 10 10 10 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 10 10 10 
Total 500 500 500 500 500 500 500 500 
 
Evaluation of aceclofenac fast dissolving tablets: 
Hardness test 
Hardness demonstrates the ability of a tablet to withstand 
mechanical shocks while handling. The hardness of the tablet 
was determined using Monsanto hardness tester and 
expressed in kg/cm² 10 
Uniformity of weight: 
Weight variation test was done with 20 tablets. The 
individual tablet weight variation from the average weight of 
20 tablets. 
Friability:  
The friability of tablets was measured using a Roche 
fribilator. At 25 rpm tablets were rotated for 4 minutes or up 
to 100 revolutions. Then the tablets were reweighed after 
removal of fines and the percentage of weight loss was 
calculated. 
F  
Drug content uniformity:  
For content uniformity, ten tablets were weighed and 
powdered a quantity of powder equivalent to 10mg of 
aceclofenac, which was extracted into 7.4 phosphate buffer 
and filtered. The aceclofenac content was calculated by 
measuring the absorbance spectrophotometrically at 274 nm 
after appropriate dilution with 7.4 phosphate buffer. The 
drug content was measured as an average of three 
determinations 11. 
Wetting Time: 
The wetting time of tablets was measured using a very 
simple procedure five circular tissue papers of 10 cm 
diameter were placed in a petridish with a 10 cm diameter. 
Ten ml of water containing a water soluble dye (amaranth) 
was added to the petridish. A tablet was carefully placed on 
the tissue paper. Time needed for water to reach the upper 
surface of the tablet was noted as wetting time 12, 13.   
Water absorption ratio: 
 A piece of tissue paper folded twice in a small petridish 
containing 6 ml of water. A tablet was kept on the tissue 
paper and allowed to wet completely. The wetted tablet was 
then weighed. Water absorption ration R was determined 
using following equation. 
         
Where, 
Wd = weight of tablet after water absorption. 
We = weight of tablet before water absorption. 
In – vitro disintegration time: 
Disintegration time for FDTs was determined using USP 
disintegration apparatus 0.1 N HCl buffer. The volume of 
medium was 900 ml and temperature was 37 ± 0.20C. The 
time in second taken for complete disintegration of the tablet 
with no palatable mass remaining in the apparatus was 
determined 14. 
In – vitro dissolution studies:  
The in- vitro dissolution rate study  of aceclofenac  fast 
dissolving tablets were performed using 8 stage dissolution 
test apparatus ( Electrolab TDT-08L) fitted with paddles (50 
rpm) at 37 ± 0.50C, using 7.4 phosphate buffer (900 ml) as a 
dissolution media. At the predetermined time intervals, 5 ml 
samples were withdrawn, filtered through 0.45µ membrane 
filter, diluted and assayed at 274 nm using a Analytical 
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technology T360 UV/Visible Double beam 
spectrophotometer. Cumulative percentage release was 
measured using standard absorbance from the calibration 
curve. All the dissolution experiments were conducted in 
triplicate (n = 3). 
RESULTS AND DISCUSSION 
The starch glutarate prepared was found to be fine, free 
flowing slightly amorphous powder. The physical and 
micromeritics properties of the starch glutarate are 
summarized in table 2. It was insoluble in aqueous solvents 
and insoluble in organic solvents tested (methanol, 
petroleum ether, dichloromethane, and chloroform) the pH 
of 3% aqueous dispersion. 
Starch glutarate exhibited good swelling in water. The 
swelling index was 50% all micrometric properties resulted 
good flow and compressibility needed for solid dosage from 
manufacturing. The density of starch glutarate was found to 
be 1.0044 g/cc. The angle of repose and compressibility 
index showed good flow properties of starch glutarate. The 
FTIR spectrum of potato starch  and  starch glutarate is 
shown in fig: 1 and 2. The presence of peaks absorption at 
2908.38 cm-1and 2927.26 cm-1 characteristic peaks of ester, 
so from FTIR studies it was concluded that starch glutarate 
(ester) was formed when starch was allowed to react with 
formic acid. The X-ray diffraction pattern (fig: 3) of starch 
glutarate showed no peaks, which indicates that the 
structure is slightly amorphous. The disappearance of pink 
colour in the ester test confirmed the presence of ester, i.e., 
starch glutarate. As the starch glutarate was slightly 
amorphous powder and it had got all the characteristic of 
superdisintegrants it was concluded that starch glutarate can 
be used as novel superdisintegrant in the formulation of fast 
dissolving tablets. 
 
Table: 2. Physical and micromeritics properties of the starch glutarate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested 
pH(1% w/v aqueous dispersion) 3.5% 
Melting Point Charred at 178º C 
Viscosity(1% w/v aqueous dispersion) 0.8422cps 
Swelling index 50% 
Gelling property 
No gelling and the swollen particles of starch glutarate separated from water. 
Where as in the case of starch, it was gelatinized and formed gel. 
Particle Size 136 µm (80/120 mesh) 
Density 1.0044 g/cc 
Bulk Density 2 g/cc 
Angle of Repose 18.40 
Compressibility Index 25% 
   
 
              Figure 1: Fourier transform infrared spectra of potato starch. 
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Figure 2: Fourier transform infrared spectra of starch glutarate 
 
 
Figure 3: X-Ray diffraction pattern of starch glutarate 
 
The X-ray diffraction pattern of starch glutarate showed no 
charactersistic peaks, which indicates that structure is 
amorphous. The compatibility of starch glutarate with the 
selected drug (aceclofenac) was evaluated by DSC, FTIR 
studies. The DSC thermograms of aceclofenac and 
aceclofenac – starch glutarate are shown in Fig.4 and 5. The 
DSC thermograms of aceclofenac and aceclofenac– starch 
glutarate exhibited exothermic peaks at 152.570C and 
152.510C respectively. These melting peaks of aceclofenac 
and aceclofenac – starch glutarate are nearer to the melting 
points of aceclofenac (149-1530C). The peaks observed in the 
DSC thermograms of aceclofenac and aceclofenac – starch 
glutarate mixtures correspond to the melting points of the 
respective drug indicating no interactions between the 
selected drug and starch glutarate polymer. The DSC study, 
thus, indicated no interaction between starch glutarate and 
selected drug. 
The FTIR spectra of aceclofenac and aceclofenac – starch 
glutarate are shown in Figs.6 and 7. The characteristic FTIR 
bands of aceclofenac at 2968.92 cm-1 (COOH), and 
aceclofenac – starch glutarate  at 2966.28 cm-1(COOH) were 
all observed in the FTIR spectra of both aceclofenac and 
aceclofenac – starch glutarate. These FTIR spectra 
observations also indicated no interaction between starch 
glutarate and the drug selected. 
Thus the result of DSC, FTIR indicated no interaction 
between the selected drug and starch glutarate, the new 
superdisintegrant. Hence starch glutarate could be used as a 
superdisintegrant in the design of fast dissolving tablets of 
the selected drug. 
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Figure 4:  DSC Thermogram of aceclofenac pure drug 
 
Figure 5: DSC Thermo gram of aceclofenac with starch Glutarate 
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Figure 6: FTIR spectra of aceclofenac  
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Figure 7: FTIR Spectra of aceclofenac with starch glutarate    
 
Evaluation of tablets 
Hardness 
Hardness of tablets from all batches was found to be in the 
range of 3.6±0.04 kg/cm2to 3.9±0.01 kg/cm2. All tablets 
were found hard enough so that they could easily withstand 
the handling and storage conditions without getting broken. 
Friability 
All the tablets exhibited acceptable friability as none of the 
tested batches showed percentage friability that exceeded 
1%. As per IP, percent friability below 1% is an indication of 
good mechanical resistance of the tablets. Percent friability 
of all batches found in the range of 0.12%-0.15 %. Thus, it 
was proved that tablets could withstand the pressure, 
mechanical shocks during handling, transportation, storage 
and manufacturing processes. 
Drug content 
Drug content of all the formulation batches was found to be 
between 97.34±0.71 to 99.83±0.56. Hence, it can be 
concluded that all the formulations are having an accurate 
amount of drug distributed uniformly in powder mass and 
followed acceptable limits as per IP 15. i.e. 85 to 115 % of 
average content table 3. 
Disintegration studies 
In vitro disintegration time was done by the USP dissolution 
apparatus. The disintegration rate has a correlation with 
water absorption capacity of disintegrate and The In vitro 
disintegration time was found between 30 ±0.02 to 2480 ± 
0.02 s. The outcomes were tabulated and data demonstrated 
in table 3. It was found that the formulation F8 will show 
least disintegration time 30s as compare to other 
formulation. The order for a disintegration time in fast 
dissolving tablet was found to be F8<F7<F6<F5 
<F4<F3<F2<F1. The order of disintegration time may be due 
to the interaction and main effects of the super disintegrants 
used in the fast dissolving tablets. 
Water absorption ratio and wetting time 
The water absorption ratio was in between 26±0.12-
100±0.27. The wetting time found between 30±0.17-
170±0.02. The outcomes were tabulated and data 
demonstrated in table 3 and Fig. 8 and 8a. It was found that 
the formulation F8 containing 5 % starch glutarate, 5% 
crospovidone and 5 % croscarmellose sodium showed less 
wetting time i.e. 30±0.17s as compared to other 
formulations. 
In vitro dissolution studies 
Dissolution rate depends on the wetting time of the 
disintegrant, among all the formulations F8 has less wetting 
time and has greater dissolution rate and then this is the 
other conformance test for correct selection of desirable. In 
vitro dissolution studies of all the formulation were done and 
depicted in fig. 9. In all formulations F8 formulation was 
selected as the promising formulation containing 5 % stach 
glutarate, 5% crospovidone and 5 % croscarmellose  sodium 
with 99.15% release in 15 min which may be due to the 
interaction effect between the two super disintegrants i.e., 
starch glutarate, crospovidone and croscarmellose sodium at 
a concentration of 5 % each. The dissolution parameters of 
the formulation from (F1–F8) which were made by direct 
compression method were shown in the table 4. In all these 
cases the PD5 (percent dissolved in 5 minute) was more in F8 
which consists at 5 % starch glutarate, 5% crospovidone and 
5 % croscarmellose sodium. The same was in the case of DE5 
% (dissolution efficiency in 5 min). The PD5 & DE5 % revels 
that starch glutarate was effective at 5%, crospovidone at 
5% along with 5 % croscarmellose sodium when the 
formulations were made by direct compression using these 
superdisintegrants. The K1 decreased in all the formulation 
when compared to F1 formulation which was given in the 
table 4. The number of folds increases in DE5% and number 
of folds increase in K1 (min -1) were given to the table 4.  
From the results, it was concluded that starch glutarate (new 
super disintegrant) could be used as a super disintegrant in 
the formulation of fast dissolving tablets of aceclofenac. To 
evaluate the individual and combined effects of the three 
factors involved, fast dissolving tablets were formulated 
employing selected combinations of the factors as per 23-
factorial design. The fast dissolving tablets and release 
parameters (percent drug released in 5 min) of the fast 
dissolving formulated were analyzed as per ANOVA of 23-
factorial design. ANOVA of percentage dissolved in 5 min 
(table 5) , ANOVA of wetting time   (table 6) ,ANOVA of water 
absorption  ratio (table 7) , ANOVA of dissolution efficiency 
in 5 min (table 8) indicated that the individual effects of 
starch  glutarate (A), crospovidone (B), crosscarmellose 
sodium (C) as well as the combined effects of AB, AC, BC and 
ABC factors, were significant (P<0.05) on percentage 
dissolved in 5min ,wetting time, water absorption ratio and 
dissolution efficiency in 5 min of aceclofenac fast dissolving 
tablets.  
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Fast dissolving tablets formulated employing starch 
glutarate (5%), crospovidone  (5%) and croscarmellose 
sodium (5%) as super disintegrants exhibited in percentage 
dissolved in 5 min, wetting time, water absorption ratio  and 
dissolution efficiency in 5 min. Formulation F8 gave release 
of 99.15% in 15 min fulfilling the official specification, based 
on percentage dissolved in 5 min, wetting time, water 
absorption ratio and dissolution efficiency in 5 min. 
Formulation F8 is considered as a good fast dissolving tablet 
formulations of aceclofenac which was found to better than 
the aceclofenac fast dissolving tablets formulated by 
Manohara P et al 15. 
 
Table 3: Physical Properties: Hardness, Friability Drug Content of aceclofenac fast dissolving tablets prepared by direct 
compression method. 
Formulation 
Hardness 
(kg/cm2)n± S.D 
Friability (%) 
n± S.D 
Drug Content 
mg/tab) n± S.D 
Disintegration Time 
(sec) n± S.D 
Water Absorption 
Ratio (%) n± S.D 
F1 3.6 ± 0.01 0.12±0.013 97.58±0.71 2480 ± 0.02 26 ± 0.12 
F2 3.6 ± 0.03 0.13±0.015 98.1 ± 0.79 1440 ± 0.03 32 ± 0.18 
F3 3.6 ± 0.01 0.14±0.012 99.45±0.63 1380 ±0. 02 44 ± 0.16 
F4 3.6 ± 0.04 0.12±0.014 98.56±0.55 33 ±0. 02 56 ± 0.15 
F5 3.7 ± 0.03 0.14±0.012 99.83±0.56 32 ± 0.01 63± 0.21 
F6 3.9 ± 0.01 0.15±0.012 99.34±0.18 38 ± 0.02 67 ± 0.12 
F7 3.7 ± 0.02 0.14±0.014 99.56±0.57 33 ±0. 01 91 ± 0.15 
F8 3.6 ± 0.04 0.12±0.013 99.17±0.11 30 ± 0.02 100 ± 0.27 
*SD Standard Deviation from mean, n=3 
 
                           F1of aceclofenac Fast dissolving Tablet                                      F2 of aceclofenac fast dissolving tablet 
At time = 0 sec         At time = 170sec                                         At time = 0 sec          At time  = 70 sec 
                          
                           
                            F3 of aceclofenac fast dissolving tablet                                    F4 of aceclofenac fast dissolving tablet    
At time = 0 sec              At time = 50 sec                                      At time = 0 sec                 At time = 44 sec 
                                      
                           
                            Figure 8(A): Aceclofenac fast dissolving tablets Prepared Employing starch glutarate. 
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F5 of aceclofenc   fast   Dissolving Tablet                           F6 aceclofenac fast dissolving tablet 
At time = 0 sec              At time = 45 sec                               At time = 0 sec           At time = 43 sec 
               
F7 of aceclofenc fast dissolving tablet              F8 of aceclofenac fast dissolving tablet 
At time = 0 sec              At time = 33 sec                               At time = 0 sec              At time = 30 sec 
                     
Figure 8(B): Aceclofenac fast dissolving tablets prepared employing starch glutarate. 
 
 
Figure 9(A): Dissolution profiles of aceclofenac fast 
dissolving tablets prepared employing starch glutarate 
(F1- F4) 
 
Figure 9(B): Dissolution profiles of aceclofenac fast 
dissolving tablets prepared employing starch glutarate 
(F5-F8) 
     
 
Figure 10(A): Time Vs Log percent drug undissolved plots 
for aceclofenac  fast dissolving tablets prepared employing 
starch glutarate  (F1- F4)  
 
Figure 10(B): Time Vs Log percent drug undissolved plots 
for aceclofenac fast dissolving tablets prepared                                                                                        
employing starch glutarate (F5- F8)
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Table 4: Dissolution parameters of aceclofenac fast dissolving tablets formulated employing starch glutarate. 
 
Time(mins) 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
 
F8 
 
PD5 
 
2.75 
 
41.08 
 
35.97 
 
61.42 
 
30.34 
 
45.99 
 
61.74 
 
73.62 
 
DE5 % 
 
1.2 
 
6.7 
 
12.2 
 
31.6 
 
14 
 
21.8 
 
32 
 
43 
 
No of folds increase in DE5 % 
 
0.60 
 
0.43 
 
0.93 
 
1.05 
 
3.54 
 
3.54 
 
3.54 
 
0.82 
 
K1 (min-1) 
 
0.0092 
 
0.10 
 
0.05 
 
0.14 
 
0.06 
 
0.15 
 
0.13 
 
0.20 
 
No of folds increase in K1 (min-1)  
 
0.1 
 
0.2 
 
0.4 
 
0.5 
 
- 
 
1.6 
 
- 
 
0.7 
 *SD standard deviation from mean, n=3, PD5--percent dissolved in 5 min., DE5%-dissolution efficiency in 5 min., K1 =first order 
rate constant 
Table 5 ANOVA of   percentage dissolved in 5 min of aceclofenac fast dissolving tablets formulated employing starch 
glutarate. 
Source of Variation d. f S.S M.S.S 
Variance 
ratio 
Result 
Replicates 2 0.02 0.01 0.5 P > 0.05 
Treatments 7 1038.4 1482.91 74145.5 P ˂ 0.05 
Starch glutarate (A) 1 3106.96 3106.96 155348 P ˂ 0.05 
Crospovidone(B)          1 475.43 475.43 23771.5 P ˂ 0.05 
Starch glutarate + Crospovidone (AB) 1 99.51 99.51 4975.5 P ˂ 0.05 
Croscarmellose sodium  (C) 1 1846.08 1846.08 92304 P ˂ 0.05 
Starch glutarate+ Croscarmellose  sodium (AC) 1 501.87 501.87 25093.5 P ˂ 0.05 
Crospovidone+ Croscarmellose sodium (BC) 1 12.95 12.95 647.5 P ˂ 0.05 
Starch glutarate+ Crospovidone+  Croscarmellose sodium (ABC) 1 33.39 33.39 1669.5 P ˂ 0.05 
Error 14 0.38 0.02 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance.  
Table 6 ANOVA of wetting time of aceclofenac fast dissolving tablets formulated employing starch glutarate. 
Source of Variation d. f S.S M.S.S 
Variance 
ratio 
Result 
Replicates 2 14.25 7.12 59.33 P < 0.05 
Treatments 7 2496 356.57 2971.41 P ˂ 0.05 
Starch glutarate (A) 1 54 54 450 P ˂ 0.05 
Crospovidone(B)          1 661.5 661.5 5512.5 P ˂ 0.05 
Starch glutarate + Crospovidone (AB) 1 54 54 450 P ˂ 0.05 
Croscarmellose sodium  (C) 1 176 176 1466.66 P ˂ 0.05 
Starch glutarate+ Croscarmellose  sodium (AC) 1 24 24 200 P ˂ 0.05 
Crospovidone+ Croscarmellose sodium (BC) 1 253.5 253.5 2112.5 P ˂ 0.05 
Starch glutarate+ Crospovidone+  Croscarmellose sodium (ABC)    1   24     24             200   P ˂ 0.05 
Error 14 1.75 0.12 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance. 
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Table 7 ANOVA of water absorption of time of aceclofenac fast dissolving tablets formulated employing starch glutarate. 
Source of Variation d. f S.S M.S.S 
Variance 
ratio 
Result 
Replicates 2 31.58 15.79 225.57 P < 0.05 
Treatments 7 14567.29 2081.04 29729.14 P ˂ 0.05 
Starch glutarate (A) 1 376.04 376.04 5372 P ˂ 0.05 
Crospovidone(B)          1 4030.4 4030.4 57577.14 P ˂ 0.05 
Starch glutarate + Crospovidone (AB) 1 45.37 45.37 648.14 P ˂ 0.05 
Croscarmellose sodium  (C) 1 9963.37 9963.37 142333.85 P ˂ 0.05 
Starch glutarate+ Croscarmellose  sodium (AC) 1 7.04 7.04 100.57 P ˂ 0.05 
Crospovidone+ Croscarmellose sodium (BC) 1 145.04 145.04 2072 P ˂ 0.05 
Starch glutarate+ Crospovidone+  Croscarmellose sodium (ABC) 1 0.37 0.37 5.28 P ˂ 0.05 
Error 14 1.09 0.07 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance. 
 
Table 8 ANOVA of Dissolution Efficiency in 5min of Aceclofenac Fast Dissolving Tablets Formulated employing starch 
glutarate. 
Source of Variation d. f S.S M.S.S 
Variance 
ratio 
Result 
Replicates 2 3.06 1.53 7.28 P < 0.05 
Treatments 7 4311.57 615.93 2933 P ˂ 0.05 
Starch glutarate (A) 1 425.88 425.88 2028 P ˂ 0.05 
Crospovidone(B)          1 2115.00 2115.00 10071.42 P ˂ 0.05 
Starch glutarate + Crospovidone (AB) 1 110.94 110.94 528.28 P ˂ 0.05 
Croscarmellose sodium  (C) 1 1309.80 1309.80 6237.14 P ˂ 0.05 
Starch glutarate+ Croscarmellose  sodium (AC) 1 5.70 5.70 27.14 P ˂ 0.05 
Crospovidone+ Croscarmellose sodium (BC) 1 4.08 4.08 19.42 P ˂ 0.05 
Starch glutarate+ Crospovidone+  Croscarmellose sodium (ABC) 1 43.74 43.74 208.28 P ˂ 0.05 
Error 14 3.04 0.21 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance. 
CONCLUSION                                                            
Starch glutarate is an efficient superdisintegrant for fast 
dissolving tablets. The disintegration and dissolution 
efficiency of the fast dissolving tablets of aceclofenac was 
good and depended on the concentration of 
superdisintegrant employed i.e., starch glutarate(5%), 
crospovidone (5%) and crosscarmellose sodium (5%). The 
formulated fast dissolving tablets of aceclofenac employing 
starch glutarate, crospovidone and crosscarmellose sodium 
exhibited good dissolution efficiency in 15 min which can be 
used for the fast therapeutic action of Aceclofenac.   
Overall, Starch glutarate was found to be a superdisintegrant 
which enhanced the dissolution efficiency when combined 
with crospovidone and croscarmellose sodium, with the 
aceclofenac and hence it could be used in the formulation of 
fast dissolving tablets to provide immediate release of the 
contained drug within 15 min. 
Abbreviations 
FTIR - Fourier transform infrared spectra  
DSC - Differential scanning calorimetry 
ANOVA – Analysis of variance  
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